{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:56:43Z","timestamp":1793451403812,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100019717","name":"AstraZeneca Farmaceutica Spain SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jacc.2024.04.036","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T18:31:32Z","timestamp":1718649092000},"page":"2629-2639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Timing of P2Y12 Inhibitor Administration in Patients With STEMI Undergoing Primary PCI"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7144-4782","authenticated-orcid":false,"given":"Manuel","family":"Almendro-Delia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Hern\u00e1ndez-Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Padilla-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Blanco-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Andres","family":"Arboleda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Rodr\u00edguez-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Soto-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Castillo-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Garc\u00eda-Rubira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Hidalgo-Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.04.036_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.04.036_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2012.11.018","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.04.036_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2022.10.023","article-title":"Timing, selection, modulation, and duration of P2Y12 inhibitors for patients with acute coronary syndromes undergoing PCI","volume":"16","author":"Capodanno","year":"2023","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2024.04.036_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCINTERVENTIONS.112.972323","article-title":"Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction","volume":"5","author":"Alexopoulos","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.04.036_bib5","article-title":"Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"8","author":"Parodi","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.04.036_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4244\/EIJ-D-17-00852","article-title":"The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis","volume":"14","author":"Bellemain-Appaix","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2024.04.036_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.04.036_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00392-011-0393-1","article-title":"Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial","volume":"101","author":"Zeymer","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2024.04.036_bib9","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1016\/j.ijcard.2013.07.012","article-title":"Comparison of pre-hospital 600\u00a0mg or 900\u00a0mg vs. peri-interventional 300\u00a0mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load and Go randomized trial","volume":"168","author":"Ducci","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.04.036_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.amjcard.2015.01.531","article-title":"Prognostic impact of clopidogrel pretreatment in patients with acute coronary syndrome managed invasively","volume":"115","author":"Almendro-Delia","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2024.04.036_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ahj.2010.04.018","article-title":"Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary intervention","volume":"160","author":"Larson","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.04.036_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005528","article-title":"No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"11","author":"Koul","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.04.036_bib13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ccd.27863","article-title":"Time-dependent benefits of pre-treatment with new oral P2Y12-inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction","volume":"93","author":"Pepe","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.04.036_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/eurheartj\/ehz069","article-title":"Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry","volume":"40","author":"Redfors","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.04.036_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ccd.29144","article-title":"The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention","volume":"97","author":"d'Entremont","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.04.036_bib16","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/ccd.30153","article-title":"Effect of prehospital treatment in STEMI patients undergoing primary PCI","volume":"99","author":"Fabris","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2024.04.036_bib17","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2024.04.036_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.887748","article-title":"Comparative safety and effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndrome: an on-treatment analysis from a multicenter registry","volume":"9","author":"Almendro-Delia","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2024.04.036_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.recesp.2023.05.008","article-title":"Nonadherence to ticagrelor versus clopidogrel and clinical outcomes in patients with ACS","volume":"77","author":"Almendro-Delia","year":"2024","journal-title":"Results from the CREA-ARIAM registry Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacc.2024.04.036_bib20","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Academic Research Consortium. standardized end point definitions for coronary intervention trials: The Academic Research Consortium-2 Consensus Document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.04.036_bib21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jacc.2013.10.022","article-title":"Impact of intraprocedural stent thrombosis during percutaneous coronary intervention:insights from the CHAMPION PHOENIX Trial","volume":"63","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.04.036_bib22","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.04.036_bib23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1214\/aoms\/1177704172","article-title":"Estimation of location based on ranks","volume":"34","author":"Hodges","year":"1963","journal-title":"Ann Math Statist"},{"key":"10.1016\/j.jacc.2024.04.036_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.0006-341X.2000.00779.x","article-title":"Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests","volume":"56","author":"Robins","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jacc.2024.04.036_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006065","article-title":"Doubly robust estimation of causal effect: upping the odds of getting the right answers","volume":"13","author":"Li","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2024.04.036_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcin.2015.12.024","article-title":"Effect of pre-hospital ticagrelor during the first 24\u00a0h after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: The ATLANTIC-H24 Analysis","volume":"9","author":"Montalescot","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2024.04.036_bib27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jacc.2010.09.077","article-title":"Composition of coronary thrombus in acute myocardial infarction","volume":"57","author":"Silvain","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.04.036_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ahj.2017.10.021","article-title":"Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study","volume":"196","author":"Bagai","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2024.04.036_bib29","article-title":"Clinical impact of intraprocedural stent thrombosis during percutaneous coronary intervention in patients treated with potent P2Y12 inhibitors -a VALIDATE-SWEDEHEART Substudy","volume":"10","author":"Bergman","year":"2021","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724070529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724070529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:28:41Z","timestamp":1750811321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724070529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0735109724070529"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.04.036","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing of P2Y12 Inhibitor Administration in Patients With STEMI Undergoing Primary PCI","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}